Clinical trial
A Chart Review to Evaluate the Safety and Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on Subjects With Autism Spectrum Disorder (ASD)
NCT02758496 is registered in ClinicalTrials.gov with Wave Neuroscience as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Chart Review to Evaluate the Safety and Efficacy of Magnetic EEG/ECG-Guided Resonance Therapy (MeRT) on Subjects With Autism Spectrum Disorder (ASD)
- Lead sponsor
- Wave Neuroscience
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- April 30, 2017
- Enrollment
- 141 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.